ニュース
Novo Nordisk ends partnership with Hims & Hers, causing a 35% plunge. With no near-term catalysts, learn why investors must ...
GPs will be prescribing Mounjaro to a select few people as the rollout begins, but others may need to avoid the jabs completely ...
Dr Willie told Reach: “You should speak to your doctor about any conditions or medications before taking any weight loss ...
Thousands are now eligible to get Mounjaro through the NHS, but some may need to avoid it and it might not even work for ...
Ireland’s medicines watchdog has confirmed a number of reports of pancreatitis linked to weight loss jabs. GLP-1 drugs like ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Obesity remains one of the greatest health challenges worldwide, leading to diabetes, heart disease, and increased healthcare ...
Hims & Hers rebounded by 11.76 percent on Thursday to close at $46.28 apiece amid reaffirmations to continue offering cheaper ...
6 時間
Dagens.com on MSNWHO Reaffirms Lab Leak as Possible COVID-19 Origin, Citing Lack of Chinese CooperationThe World Health Organization has reiterated that a laboratory accident remains a possible origin of the COVID-19 pandemic, as global investigations continue to face major obstacles due to limited ...
Mounjaro users in the UK have to jump through quite a few hoops to get their hands on the weight-loss drug. You might think ...
Having to take Ozempic or other weight loss drugs can be a real pain in the ass, with users often having to jab themselves ...
Novo Nordisk has launched its weight-loss drug Wegovy in India, while Eli Lilly's Mounjaro has received regulatory approval, ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する